Personal information

Activities

Collapse all

Employment (2)

Batavia Biosciences BV: Leiden, Zuid-Holland, NL

2019-04-01 to present | Director of Science and Innovation
Employment
Source: Self-asserted source
Wilfried A.M. Bakker

Intravacc: Bilthoven, Utrecht, NL

2006-04-01 to 2019-04-01 | Program Manager Viral Vaccines
Employment
Source: Self-asserted source
Wilfried A.M. Bakker

Education and qualifications (2)

Wageningen University and Research Centre: Wageningen, NL

1990 to 1995 | PhD (Dutch: Dr.)
Education
Source: Self-asserted source
Wilfried A.M. Bakker

Wageningen University and Research Centre: Wageningen, NL

1984 to 1990 | MSc (Dutch: Ir.)
Education
Source: Self-asserted source
Wilfried A.M. Bakker

Works (3)

Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective

Journal of Molecular Medicine
2022-06 | Journal article
DOI: 10.1007/s00109-022-02208-0
Contributors: Schwartze JT; Havenga M; Bakker WAM; Bradshaw AC; Nicklin SA
Source: check_circle
Crossref

Stable, high yield expression of gp145 Env glycoprotein from HIV-1 in mammalian cells

Biologicals
2021-09 | Journal article
DOI: 10.1016/j.biologicals.2021.07.004
Contributors: Abhinav Luthra; Sarwat Cheema; Stephen Whitney; Wilfried A.M. Bakker; Ziv Sandalon; James Richardson; Chris Yallop; Menzo Havenga
Source: check_circle
Crossref

Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development

2021-03-14 | Preprint
DOI: 10.1101/2021.03.11.435055
Contributors: Mónika Z. Ballmann; Svjetlana Raus; Ruben Engelhart; Győző L. Kaján; Chantal van der Zalm; Tibor Papp; Lijo John; Selina Khan; Jerome Custers; Wilfried A.M. Bakker et al.
Source: check_circle
Crossref
How many people are using ORCID?